Form D · Other Health Care

AngioInsight, Inc.

Minnetonka, MN · CIK 0002164579

Offering snapshot reported Nov 10, 2026 · SEC filing

Reported sold
$16.3M
Offering amount: $20M
Investors reported
94
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 9, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 10, 2026Initial$16,314,000No comparison94SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$761K (estimated)
Finders' fees
$0
Form D file number
021-604236
10% of the proceeds received from the sale of SAFEs by the Broker

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cedar Point Capital, LLC145116Cedar Point Capital, LLC · CRD 145116

Source: Form D, filed Nov 10, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Laurence L. Betterley Director
Scott Burger Director, Executive
Shlomi Nachman Director
Serafin Samson Director
Mark Summers Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
601 Carlson Parkway
Minnetonka, MN, 55305